{"id":"https://openalex.org/W4394515403","doi":"https://doi.org/10.6084/m9.figshare.23551920","title":"Supplementary Material for: Assessing the clinical and endoscopic efficacy of extended duration treatment with different doses of mesalazine for mild to moderate ulcerative colitis beyond 8 weeks of induction","display_name":"Supplementary Material for: Assessing the clinical and endoscopic efficacy of extended duration treatment with different doses of mesalazine for mild to moderate ulcerative colitis beyond 8 weeks of induction","publication_year":2023,"publication_date":"2023-01-01","ids":{"openalex":"https://openalex.org/W4394515403","doi":"https://doi.org/10.6084/m9.figshare.23551920"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/23551920","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Material_for_Assessing_the_clinical_and_endoscopic_efficacy_of_extended_duration_treatment_with_different_doses_of_mesalazine_for_mild_to_moderate_ulcerative_colitis_beyond_8_weeks_of_induction/23551920","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/dataset/Supplementary_Material_for_Assessing_the_clinical_and_endoscopic_efficacy_of_extended_duration_treatment_with_different_doses_of_mesalazine_for_mild_to_moderate_ulcerative_colitis_beyond_8_weeks_of_induction/23551920","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057899912","display_name":"Geert D\u2019Haens","orcid":"https://orcid.org/0000-0003-2784-4046","observed_orcids":["https://orcid.org/0000-0003-2784-4046"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G., D'Haens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014026215","display_name":"Ekaterina Safroneeva","orcid":"https://orcid.org/0000-0002-1505-7750","observed_orcids":["https://orcid.org/0000-0002-1505-7750"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E., Safroneeva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016547253","display_name":"Helen C. Thorne","orcid":"https://orcid.org/0000-0002-6422-4623","observed_orcids":["https://orcid.org/0000-0002-6422-4623"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H., Thorne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069318729","display_name":"R Laoun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R., Laoun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13569","display_name":"Microscopic Colitis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":0.984000027179718},{"id":"https://openalex.org/keywords/5-aminosalicylic-acid","display_name":"5-aminosalicylic acid","score":0.9929999709129333},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.75},{"id":"https://openalex.org/keywords/endoscopic-remission","display_name":"endoscopic remission","score":0.8040000200271606},{"id":"https://openalex.org/keywords/clinical-remission","display_name":"clinical remission","score":0.9940000176429749},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.593999981880188},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.597000002861023},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C2779174533","wikidata":"https://www.wikidata.org/wiki/Q412479","display_name":"Mesalazine","level":4,"score":0.9820377230644226},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.8821210861206055},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.68288254737854},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5011708736419678},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4917047619819641},{"id":"https://openalex.org/C112758219","wikidata":"https://www.wikidata.org/wiki/Q16038819","display_name":"Duration (music)","level":2,"score":0.41983911395072937},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.05498689413070679},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.04703977704048157},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:figshare.com:article/23551920","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Material_for_Assessing_the_clinical_and_endoscopic_efficacy_of_extended_duration_treatment_with_different_doses_of_mesalazine_for_mild_to_moderate_ulcerative_colitis_beyond_8_weeks_of_induction/23551920","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.23551920","doi":"https://doi.org/10.6084/m9.figshare.23551920","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.23551920","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.23551920.v1","doi":"https://doi.org/10.6084/m9.figshare.23551920.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.23551920.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/23551920","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Material_for_Assessing_the_clinical_and_endoscopic_efficacy_of_extended_duration_treatment_with_different_doses_of_mesalazine_for_mild_to_moderate_ulcerative_colitis_beyond_8_weeks_of_induction/23551920","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4382599827","https://openalex.org/W2914782795","https://openalex.org/W2914422079","https://openalex.org/W2020934609","https://openalex.org/W2155979581","https://openalex.org/W7095526319","https://openalex.org/W2330812274","https://openalex.org/W2013188860","https://openalex.org/W3206030161","https://openalex.org/W4220796557"],"abstract_inverted_index":{"Introduction:":[0],"High-strength":[1],"mesalazine":[2,34,54,147,153,230],"formulations":[3],"play":[4],"an":[5,71,223,234,243,249],"important":[6],"role":[7],"in":[8,17,42,109,248],"providing":[9],"a":[10,77,149],"convenient":[11],"option":[12],"to":[13,27,44,128,222,245,251],"increase":[14,244],"the":[15,25,92,239],"dose":[16,226],"ulcerative":[18],"colitis":[19],"(UC)":[20],"patients":[21,69,164,192],"and":[22,104,119,125,131,137,161,167,178,189,200,211,255],"therefore":[23],"avoiding":[24],"switch":[26],"another":[28],"therapeutic":[29],"class.":[30],"Higher":[31],"doses":[32,56],"of":[33,40,52,79,115,146,198,204,227],"may":[35],"be":[36],"required":[37],"during":[38],"periods":[39],"remission":[41,169,195],"order":[43],"prevent":[45],"relapse.":[46],"Aim:":[47],"To":[48],"investigate":[49],"clinical":[50,103,132,166,194,254],"outcomes":[51],"three":[53,99],"maintenance":[55],"adapted":[57],"for":[58,76],"post":[59],"induction":[60,85,93,225],"response.":[61],"Methods:":[62],"In":[63],"this":[64],"post-hoc":[65],"analysis,":[66],"675":[67],"UC":[68],"entered":[70],"open":[72],"label":[73],"extension":[74],"study":[75],"total":[78],"38":[80,172],"weeks":[81],"(including":[82],"8-12":[83],"week":[84,123,135,171,183],"period":[86,94,237],"with":[87,173,206],"3.2":[88,141,176,209,228],"g/day":[89,142,145,177,210,229,247],"mesalazine).":[90],"After":[91],"they":[95],"were":[96],"separated":[97],"into":[98],"groups:":[100],"remitters":[101],"(in":[102],"endoscopic":[105,130,168,256],"remission),":[106],"responders":[107],"(decrease":[108],"Partial":[110],"Mayo":[111],"Clinic":[112],"Score":[113],"(PMCS)":[114],"\u2265":[116,120],"2":[117],"points":[118],"30%":[121],"from":[122,233],"0)":[124,205],"non-responders":[126],"(failed":[127],"achieve":[129,252],"response":[133],"at":[134,170,238],"8)":[136],"received":[138],"1.6":[139,174,207],"g/day,":[140,175,180,208,213],"or":[143,219,242],"4.8":[144,179,212,246],"(using":[148],"new":[150],"1600":[151],"mg":[152],"tablet),":[154],"respectively.":[155,181,214],"Results:":[156],"133/202":[157],"(65.8%),":[158],"108/274":[159],"(39.4%)":[160],"59/199":[162],"(29.6%)":[163],"achieved":[165,193],"At":[182],"38,":[184],"142/202":[185],"(70.3%),":[186],"93/274":[187],"(33.9%)":[188],"61/199":[190],"(30.7%)":[191],"(stool":[196],"score":[197,203],"0":[199],"rectal":[201],"bleeding":[202],"Conclusions:":[215],"Patients":[216],"partially":[217],"responding":[218,221],"not":[220],"initial":[224],"could":[231],"benefit":[232],"extended":[235],"treatment":[236],"same":[240],"dose,":[241],"attempt":[250],"combined":[253],"remission.":[257]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2024-04-08T00:00:00"}